Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market - GBI Research Reports

Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market

Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market - GBI Research Reports
Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market
Published Dec 22, 2010
97 pages — Published Dec 22, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market' which provides insight about contraceptive sales and price forecasts until 2016. The report also delves deep into global contraceptive treatment usage patterns. Further, contraceptive markets in the key geographies of the US, top five EU countries and Japan are also covered in the report. The report also includes details about contraceptive R&D pipelines and potential future blockbuster products. The report provides in-depth analysis of the main contraceptive classes, which includes oral contraceptives, injectables and topical contraceptives. Furthermore, it includes market forecasts and treatment usage patterns for each therapeutic class. The report also explores the competitive landscape, with a competitive analysis of the top companies in the market. Finally, a key trend analysis of mergers and acquisitions, and licensing agreements in the contraceptives market is also included.

Scope

The scope of this report includes:
- Data and analysis of the contraceptives market in the leading geographies which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
- Annualized market data for the contraceptives market from 2001 to 2009, with forecasts to 2016.
- Market data on the geographical landscape and therapeutic landscape, including market sizes, market shares, annual costs of therapy, sales volumes and treatment usage patterns, such as disease populations, treatment seeking populations, diagnosis populations and prescription populations.
- Key drivers and restraints that have had significant impact on the market.
- Competitive landscape of the global contraceptives market including benchmarking of the top companies. The key companies studied in this report are Merck/Schering-Plough, Pfizer/Wyeth, Johnson and Johnson, Bayer and Warner Chilcott
- Key M&A and licensing agreements that have taken place between 2008 and 2009 in the contraceptives market

Reasons to buy

The report will aid business development and help marketing executives strategizing product launches:
- Build effective strategies to launch pipeline products, by identifying potential geographies.
- Exploit in-licensing and out-licensing opportunities by identifying products to fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of the top competitors.
- Develop market-entry and market expansion strategies, by identifying the geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety.

  
Source:
Document ID
GBIHC051MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents36
1.1 List of Tables52
1.2 List of Figures72
2 Global Contraceptives Market: Introduction91
2.1 GBI Research Report Guidance91
3 Global Contraceptives Market: Market Overview102
3.1 Introduction101
3.1.1 Drivers and Barriers111
3.1.1.1 Drivers for the Contraceptives Market 111
3.1.1.2 Barriers for the Contraceptives Market 111
3.1.2 Opportunity and Unmet Need111
4 Global Contraceptives Market: Market Characterization128
4.1 Revenue121
4.2 Annual Cost of Treatment 131
4.3 Treatment Usage Patterns142
4.3.1 Target Population161
4.3.2 Treatment Seeking Population171
4.3.3 Population Taking Prescribed Contraceptive Drugs181
4.3.4 Population Taking OTC Contraceptive Drugs191
5 Global Contraceptives Market: Geographical Landscape2025
5.1 Revenue Analysis by Geography 201
5.2 The US201
5.2.1 Revenue202
5.2.2 Annual Cost of Treatment 221
5.2.3 Treatment Usage Patterns232
5.2.3.1 Target Population251
5.2.3.2 Treatment Seeking Population261
5.2.3.3 Population Taking Prescribed Contraceptive Drugs271
5.2.3.4 Population Taking OTC Contraceptive Drugs281
5.3 Top Five Countries of Europe291
5.3.1 Revenue291
5.3.2 Annual Cost of Treatment301
5.3.3 Treatment Usage Patterns312
5.3.3.1 Target Population331
5.3.3.2 Treatment Seeking Population341
5.3.3.3 Population Taking Prescribed Contraceptive Drugs351
5.3.3.4 Population Taking OTC Contraceptive Drugs361
5.4 Japan371
5.4.1 Revenue371
5.4.2 Annual Cost of Treatment381
5.4.3 Treatment Usage Patterns392
5.4.3.1 Target Population411
5.4.3.2 Treatment Seeking Population421
5.4.3.3 Population Taking Prescribed Contraceptive Drugs431
5.4.3.4 Population Taking OTC Contraceptive Drugs441
6 Global Contraceptives Market: Therapeutic Landscape 4524
6.1 Oral Contraceptives Market451
6.1.1 Revenue451
6.1.2 Annual Cost of Treatment461
6.1.3 Treatment Usage Patterns472
6.1.3.1 Target Population491
6.1.3.2 Treatment Seeking Population501
6.1.3.3 Population Taking Prescribed Contraceptive Drugs511
6.1.3.4 Population Taking OTC Contraceptive Drugs521
6.2 Injectables Market531
6.2.1 Revenue531
6.2.2 Annual Cost of Treatment541
6.2.3 Treatment Usage Patterns552
6.2.3.1 Target Population571
6.2.3.2 Treatment Seeking Population581
6.2.3.3 Population Taking Prescribed Contraceptive Drugs591
6.2.3.4 Population Taking OTC Contraceptive Drugs601
6.3 Topical Contraceptives Market611
6.3.1 Revenue611
6.3.2 Annual Cost of Treatment621
6.3.3 Treatment Usage Patterns632
6.3.3.1 Target Population651
6.3.3.2 Treatment Seeking Population661
6.3.3.3 Population Taking Prescribed Contraceptive Drugs671
6.3.3.4 Population Taking OTC Contraceptive Drugs681
7 Global Contraceptives Market: Pipeline Analysis695
7.1 Introduction693
7.2 Profiles of Promising Drugs in the Contraceptive Market721
7.2.1.1 Overview 721
7.2.1.2 Efficacy 721
7.2.1.3 Safety 721
7.2.1.4 Clinical Study Details 721
7.2.2 Yaz Flex721
7.2.2.1 Overview 721
7.2.2.2 Efficacy 721
7.2.2.3 Safety 721
7.2.2.4 Clinical Study Details 721
7.2.3 Pill Plus731
7.2.3.1 Overview 731
7.2.3.2 Efficacy 731
7.2.3.3 Safety 731
7.2.3.4 Clinical Study Details731
8 Global Contraceptives Market: Competitive Landscape7413
8.1 Evolving competitive landscape741
8.2 Market Share Analysis751
8.2.1 Major Players761
8.3 Competitive Profiling771
8.3.1 Pfizer771
8.3.1.1 Company Overview 771
8.3.1.2 Marketed Contraceptive Drugs771
8.3.1.3 SWOT Analysis781
8.3.2 Watson781
8.3.2.1 Company Overview 781
8.3.2.2 Marketed Contraceptive Drugs781
8.3.2.3 SWOT Analysis791
8.3.3 Teva Pharmaceuticals801
8.3.3.1 Company Overview801
8.3.3.2 Marketed Contraceptive Drugs801
8.3.3.3 SWOT Analysis 811
8.3.4 Warner Chilcott Ltd.811
8.3.4.1 Company Overview 811
8.3.4.2 Marketed Contraceptive Drugs811
8.3.4.3 SWOT Analysis821
8.3.5 Johnson &Johnson831
8.3.5.1 Company Overview 831
8.3.5.2 Marketed Contraceptive Drugs831
8.3.5.3 SWOT Analysis841
8.3.6 Bayer AG841
8.3.6.1 Company Overview 841
8.3.6.2 Marketed Contraceptive Drugs851
8.3.6.3 SWOT Analysis851
8.3.7 The National Institute of Allergy and Infectious Diseases861
8.3.7.1 Company Overview 861
8.3.7.2 Marketed Contraceptive Drugs861
9 Global Contraceptives Market: M&A Landscape876
9.1 Overview871
9.1.1 M&A Deals by Value ($)871
9.1.1.1 Bayer Acquires Schering AG881
9.1.1.2 Watson Pharmaceuticals Acquires Andrx881
9.1.1.3 Barr Pharmaceuticals Acquires Rights of Mircette from Organon and Savient881
9.2 R&D Licensing Agreements 891
9.2.1 Deals by Phase891
9.2.2 Deals by Geography901
9.2.3 Phase I901
9.2.3.1 SOH-075901
9.2.4 Phase II911
9.2.4.1 EMM 310066911
9.2.5 Phase III911
9.2.5.1 WC3026911
9.2.6 Marketed Drugs921
9.2.6.1 Ulipristal Acetate (UPA)921
10 Global Contraceptives Market: Appendix935
10.1 Market Definitions931
10.2 Abbreviations931
10.3 Research Methodology935
10.3.1 Coverage931
10.3.2 Secondary Research941
10.3.3 Primary Research941
10.3.4 Forecasts941
10.3.4.1 Epidemiology-based Forecasting952
10.3.5 Expert Panel Validation971
10.4 Contact Us971
10.5 Disclaimer971
10.6 Sources971

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market" Dec 22, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Contraceptives-Market-to-2016-Demand-for-Long-Acting-Birth-Control-Pills-Encourages-Growth-in-Hormonal-Contraceptives-Market-2115-124>
  
APA:
GBI Research Reports. (2010). Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market Dec 22, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Contraceptives-Market-to-2016-Demand-for-Long-Acting-Birth-Control-Pills-Encourages-Growth-in-Hormonal-Contraceptives-Market-2115-124>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.